Forward
This guideline has been developed to assist you in preparation for and the recognition of severe respiratory diseases that may have been acquired, such as novel corona virus infection, H7N9 influenza, avian influenza, SARS or other severe respiratory infection. This guideline will be valuable when there are suspected or confirmed cases. Because of the current threat, I urge you to comply with this information in your practice.
Doctors, Pharmacists, Emergency Department Staff and other point of entry staff will be the first to be contacted by affected members of the public if such diseases appear in Bahrain. It is important that as a health care worker, you keep up-to -date with current information about such diseases.
Your vigilance in recognizing and managing these respiratory diseases is essential in the prevention of a major outbreak in Bahrain.
H.E. Sadiq AbdulKarim Al Shehabi Minister of Health
27April 2014
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The Disease
Infectious agent
This is a new strain of coronavirus that has not been previously identified in humans. Coronaviruses are a large family of viruses that are known to cause illness in humans and animals. In humans, this large family of viruses is known to cause illness ranging from the common cold to Severe Acute Respiratory Syndrome (SARS).
The new virus is a beta coronavirus. The novel coronavirus is not the same virus that caused severe acute respiratory syndrome (SARS) in 2003. However, like the SARS virus, the novel coronavirus is most similar to those found in bats.
Mode of transmission
not know yet how people become infected with this virus. Investigations are underway to determine the source of the virus, the types of exposure that lead to infection, the mode of transmission, and the clinical pattern and course of disease.
The recent study by Reusken and colleagues suggests that MERS-CoV or a virus very similar to the MERS-CoV has been recently circulating among camels. More study is needed to know whether the virus is actually the identical to that found in humans. To do this, it is important to recover the MERS virus itself from a camel.
The paper provides a very important clue to the source of the virus and a direction for further investigation. The most critical question remains to be answered, that is, the type of human exposures that result in infection. Most human cases do not have a history of direct contact with camels; if camels or other animals are the source, the route of transmission to humans may be indirect.
It is premature to rule out the possibility that other animals might serve as a reservoir or an intermediate host for the MERS-CoV. There continues to be a need for well planned, structured investigations carried out in conjunction with exposure investigations in humans.
http://www.who.int/csr/disease/coronavirus_infections/faq/en/index.html
Incubation period
The incubation period for Coronavirus is still unknown, but the incubation period of the known patterns of Corona is approximately a week, and it is thought the incubation period of the novel virus is mostly the same.
Infectious period
Still under study 27April 2014
Clinical presentation
Common symptoms are acute, serious respiratory illness with fever, cough, shortness of breath and breathing difficulties. Most patients have had pneumonia. Many have also had gastrointestinal symptoms, including diarrhoea. Some patients have had kidney failure. About half of people infected with MERS-CoV have died. In people with immune deficiencies, the disease may have an atypical presentation. It is important to note that the current understanding of illness caused by this infection is based on a limited number of cases and may change as we learn more about the virus.
Management
Currently, the best option for therapy of MERS-CoV is not well established. A recent review shed light on the possible therapeutic options for MERS-CoV. Convalescent plasma ,ribavirin and interferon are possible interventions with various level of evidence.
MERS-CoV Case Definition
Suspected case 1 
I. A person with
 one or more symptoms of acute respiratory tract infection ( e.g.fever ≥ 38°C, cough and difficulty in breathing) AND  Clinical and radiological evidence of pulmonary parenchymal disease AND  Needs admission to the hospital.
Be alert to cases coming from countries with confirmed MERS CoV infection
II. Contacts of a confirmed case of MERS CoV infection

Confirmed case
A person with laboratory confirmation of MERS-CoV infection 2 .
-
Case definition is updated according to the most recent recommendations 2 Currently confirmatory testing requires molecular diagnostics including either a positive PCR on at least two specific genomic targets or a single positive target with sequencing on a second. However, the interim recommendations for laboratory testing for MERS-CoV should be consulted for the most recent standard for laboratory confirmation 27April 2014
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What Health Care workers should do in case of a suspected MERSCoV?
If MERS-CoV is suspected, the following steps should be taken accordingly:
I. General Precautions:
1. Clinical triage should be used for early identification of all patients with Acute respiratory infections (ARIs). Identified ARIs patients should be placed in an area separate from other patients, 2. The suspected case of MERS-CoV patient should be placed in an isolation room. 3. Cohorting of suspected patients . 4. Education of HCWs about infection control measures and the importance of seeking medical care at the onset of respiratory symptoms. 5. Follow the contact and droplet precautions for respiratory infections:
 A mask, gloves and gown must be worn.  A highly protective mask (N95) and eye goggle should be used when performing an aerosol generating procedure (e.g. intubation and suction) and tracheoscopy should be performed in a negative pressure room.  Change gloves after contact with respiratory secretions or devices, or surface contaminated with secretions and between patient cares. Wash hands after glove removal.  Hands must be washed with soap or alcohol hand rubs before and after all contact with patient or the patients' environment, unless there is an exposure to patient's secretions or body fluid and there are visible contamination to wash with water and soaps.  All surfaces that have been soiled with secretions should be cleaned and disinfected with sodium hypochlorite solution. 6. Policies and procedures for all facets of occupational health should be followed , with emphasis on surveillance of (ARIs) among HCWs and monitoring of compliance by infection control team, and implementing improvements as needed. 7. If the patient needs to be transferred to the hospital by the ambulance, the team should be warned of the case and advised to take infection control precautions.
II. Immediate Reporting To Public health:
Health care providers should report all cases meeting the confirmed or probable case definition immediately by telephone to public health directorate diseases control section on the communicable diseases hotline 66399868 followed by written reporting within 24 hours. The public health specialist covering hotline should consult the Public health Consultants for case definition:  Dr. Adel Al-Sayyad, 39687214  Dr. Kubra S. Nasser, 36662055  Dr Wafa Al Sharbati,39406100
1. Algorithm (Annex I-A) and (Annex I-B) should be followed by public health specialists once they receive a notification about a case. 
VI. Suspected case identified at the boarders (airport, ports, causeway)
-isolate the patient 27April 2014
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-For suspected case : Algorithm (Annex I-A) should be initiated and case definition should be reviewed -For referral to SMC: Algorithm (Annex I-C) should be followed. -For contact: algorithm (Annex I-B) should be initiated by public health specialist.
VII. Lab testing For suspected cases :
-The case should be discussed with public health consultant before collecting the sample. -The preferred sample is deep tracheal aspirate (DTA) but nasopharyngeal swab can be collected if DTA is not possible. -Follow infection control measures during sample collection and transportation (Annex V). -The reporting physician should fill in the Laboratory Request Form (Annex III) -Blood sample (5-10 ml for adults and children and 1ml for newborns) in a plain tube and should be centrifuged and stored in two tubes at -20°C.
For confirmed cases:
-Daily nasopharyngeal swabs and blood samples until nasopharyngeal swab result becomes negative.
VIII. Case management 27April 2014
-All the suspected cases will be managed as inpatient where supportive measures such as ICU care facilities are available. 
IX. Home care for patients with MERS-CoV infection presenting with mild symptoms (Annex VIII)
-In view of the currently limited knowledge of the disease and its transmission, confirmed and probable symptomatic cases of the MERS-CoV infection should be admitted. -Patient with mild symptoms and without underlying condition at increased risk of developing complications, can be managed at home if there is no vacancy for inpatient care or in case of informed refusal of hospitalization. The patients and the household members should be educated on personal hygiene , basic infection prevention , control measures ,symptoms of deterioration and how to seek medical advice.
X. Epidemiological Investigation
 Public health staffs are responsible for completing and collecting the case investigation (Annex VI) and contact investigation Form (Annex VII).
XI. Management of contacts
Household contact: is a person who has spent an hour or more with a symptomatic lab confirmed case. Healthcare worker contact : is a healthcare worker who has spent 15 minutes or more with a symptomatic lab confirmed case.
-Nasopharyngeal and blood samples should be collected from all contacts.
-Contacts, should be advised to stay at home and their health should be monitored for 14 days from the last day of possible contact -Contacts should seek immediate medical attention if they develop symptoms, particularly fever, respiratory symptoms such as coughing or shortness of breath, or diarrhea. -A communication link with a health care provider (public health) should be available for the duration of the observation period. -The healthcare provider should give in advance instructions on where to seek care when a contact becomes ill, what should be the most appropriate mode of transportation, when and where to enter the designated health care facility, and what infection control precautions should be followed. -The receiving medical facility should be notified by public health specialist that a symptomatic contact will be coming to their facility. -While traveling to seek care, the ill individual should wear a medical mask if available and tolerated.
 Public transportation to the health care facility should be avoided, if possible. If the ill contact is transported with a private vehicle, open the windows of the vehicle if possible.  The ill contact should be advised to perform respiratory hygiene and stand or sit as far away from others as possible (at least 1 m), when in transit and when in the health care facility.  Appropriate hand hygiene should be employed by the ill contact and caregivers. Any surfaces that become soiled with respiratory secretions or body fluids during transport should be cleaned with regular household cleaners or a diluted bleach solution, whichever is most appropriate.
XII. Active search for additional cases
Efforts to identify additional cases beyond close contacts are critical for prevention and control of infection, and to determine the total extent of transmission in the community. Active case finding in the area under investigation should focus on: 
Close Contact Management
Trace all the close contacts of the index case patient and generate a contact line-listing (by telephone).  To the extent possible, assign probable or confirmed cases to be cared for exclusively by a group of skilled HCWs both for continuity of care and to reduce opportunities for inadvertent infection control breaches that could result in unprotected exposure.
Fill the contact investigation Form
 Family members and visitors in contact with a patient should be limited to those essential for patient support and should be trained on the risk of transmission and on the use of the same infection control precautions as HCWs who are providing routine care.
 In addition to Standard Precautions, all individuals, including visitors and HCWs, when in close contact (within 1 m) or upon entering the room or cubicle of patients with probable or confirmed nCoV infection should always:
 wear a medical mask;  wear eye protection (i.e. goggles or a face shield);
 wear a clean, non-sterile, long-sleeved gown; and gloves (some procedures may require sterile gloves);
 perform hand hygiene before and after contact with the patient and his or her surroundings and immediately after removal of PPE.
 If possible, use either disposable equipment or dedicated equipment (e.g. stethoscopes, blood pressure cuffs and thermometers). If equipment needs to be shared among patients, clean and disinfect it between each patient use. HCWs should refrain from touching their eyes, nose or mouth with potentially contaminated gloved or ungloved hands.
 Place patients with probable or confirmed MERS-CoV infection in adequately ventilated single rooms or Airborne Precaution rooms; if possible, situate the rooms used for isolation (i.e. single rooms) in an area that is clearly segregated from other patient-care areas. When single rooms are not available, put patients with the same diagnosis together. If this is not possible, place patient beds at least 1 m apart.
 In addition, for patients with probable or confirmed MERS-CoV infection:
 Avoid the movement and transport of patients out of the isolation room or area unless medically necessary. The use of designated portable X-ray equipment and other important diagnostic equipment may make this easier. If transport is required, use routes of transport that minimize exposures of staff, other patients and visitors.
 Notify the receiving area of the patient's diagnosis and necessary precautions as soon as possible before the patient's arrival.
 Clean and disinfect patient-contact surfaces (e.g. bed) after use.
 Ensure that HCWs who are transporting patients wear appropriate PPE and perform hand hygiene afterwards.
Duration of isolation precautions for MERS-CoV infection
The duration of infectivity for MERS-CoV infection is unknown. While Standard Precautions should continue to be applied always, additional isolation precautions should be used during the duration of symptomatic illness and continued for 24 hours after the resolution of symptoms. Given that little information is currently available on viral shedding and the potential for transmission of MERS-CoV testing for viral shedding should assist the decision making when readily available. Patient information (e.g. age, immune status and medication) should also be considered in situations where there is concern that a patient may be shedding the virus for a prolonged period.
Collection and handling of laboratory specimens
All specimens should be regarded as potentially infectious, and HCWs who collect or transport clinical specimens should adhere rigorously to Standard Precautions to minimize the possibility of exposure to pathogens.
 Ensure that HCWs who collect specimens wear appropriate PPE.
 Ensure that personnel who transport specimens are trained in safe handling practices and spill decontamination procedures. These recommendation should be followed while caring for patients with MERSCoV infection :
 Limit contact with the ill person as much as possible. The household members should stay in a different room or, if that is not possible, maintain a distance of at least one meter from the ill person (e.g. sleep in a separate bed).
 An exception may be considered for a breastfeeding mother. Considering the benefits of breastfeeding and insignificant role of the breast milk in transmission of other respiratory viruses, the mother could continue breastfeeding. The mother should wear a medical mask when she is near her baby and perform careful hand hygiene before close contact with the baby. She would need also to apply the other hygienic measures .  Ensure that anyone who is at increased risk of severe disease does not care for the ill person or come into close contact with the ill person. The current groups considered at increased risk for the MERS-CoV infection include those with chronic heart, lung or kidney conditions; diabetes; immunosuppression; blood disease; and older adults. If contact with the ill person cannot be avoided by those with an increased risk of severe disease, alternative housing should be considered.  Currently there is no evidence to suggest increased risk for the MERS-CoV infection for pregnant women, but it may be prudent to prevent them from contact with the ill person  Perform hand hygiene following all contact with the ill person or his/her immediate environment. Hand hygiene should also be performed before and after preparing food, before eating, after using the toilet, and whenever hands look dirty. Perform hand hygiene using soap and water. If hands are not visibly soiled, alcohol-based hand rub can be used.  Assistance for the ill person to perform regular hand hygiene may be provided as needed.
 Paper towels to dry hands are desirable; if they are not available, use dedicated cloth towels and replace them when they become wet.  Respiratory hygiene should be practiced by all, especially the ill person.
Respiratory hygiene refers to covering the mouth and nose during coughing or sneezing using medical masks, cloth masks, tissues or flexed elbow, followed by hand hygiene.  Discard materials used to cover the mouth or nose, or clean them appropriately after use (e.g. wash handkerchiefs using regular soap or detergent and water).  The caregiver should wear a medical mask fitted tightly to the face when in the same room with the ill person. Masks should not be touched or handled during use. If the mask gets wet or dirty with secretions, it must be changed immediately. Discard the mask after use and perform hand hygiene after removal of the mask.  Ensure that shared spaces (e.g. kitchen, bathroom) and the ill person's room are well ventilated (e.g. keep windows open).  Avoid direct contact with body fluids, particularly oral or respiratory secretions and stool.  Use disposable gloves to provide oral or respiratory care and when handling stool and urine, if possible. Perform hand hygiene after removing gloves.  Gloves, tissues, masks, and other waste generated by the ill person or in the care of the ill person should be bagged (placed in a lined container in the ill person's room) before disposal with other household waste.  Avoid other types of exposure to the ill person or contaminated items in the immediate environment of the ill person; for example, avoid sharing eating utensils, drinks, towels, washcloths or bed linen. Eating utensils and dishes should be cleaned with soap and water after use.  Clean frequently touched surfaces such as bedside tables, bedframe, and other bedroom furniture daily with regular household cleaners or a diluted bleach solution (1 part bleach to 99 parts water).  Clean bathroom and toilet surfaces daily with regular household cleaners or a diluted bleach solution (1 part bleach to 9 parts water).  Clothes, bedclothes, bath and hand towels, etc., of the ill person can be cleaned using regular laundry soap and water, and dried thoroughly. Place contaminated linen into a laundry bag. Soiled laundry should not be shaken and direct contact of the skin and clothes with the contaminated materials from the ill person should be avoided.  Consider use of disposable gloves and protective clothing (e.g. plastic aprons) when cleaning or handling surfaces, clothing or linen soiled with body fluids. Hand hygiene should be performed after glove removal.  The symptomatic person should remain at home until satisfactory resolution of the symptoms. The decision to remove the ill person from home observation should be made based on either clinical or laboratory findings or both.  All household members should be considered contacts and their health should be monitored.
